PharmaOnco™ Human CD8⁺ Cells, Cord Blood (CAT#: ITS-0622-YT558)

Creative Biolabs offers Human CD8⁺ Cells, Cord Blood for immunity reaserch.

CD8+ T cells are a type of immune cell that play a crucial role in recognizing and killing virus-infected cells, tumor cells, and other abnormal cells. CD8+ T cells derived from cord blood have unique properties that make them highly suited for use in immune therapy, including their high proliferative capacity, ability to recognize a wide range of antigens, and reduced risk of causing graft-versus-host disease when used in transplantation.

CD8+ T cells also called cytotoxic T lymphocytes (CTLs) belong to a subpopulation that express CD8 on their surface. They are a critical subpopulation of MHC class I-restricted T cell and are mediators of adaptive immunity. Adaptive CD8 T cell immunity represents an essential arm of the immune system to protect against many viral and bacterial infections and tumors.

Human

Lymphocytes, CD8+

Cord Blood

High quality;
High viability;
Widely applications.